相似文献
1
Effect of adjunctive tobramycin inhalation versus placebo on early clinical response in the treatment of ventilator-associated pneumonia: the VAPORISE randomized-controlled trial.
Intensive Care Med. 2020 Mar;46(3):546-548. doi: 10.1007/s00134-019-05914-5. Epub 2020 Jan 23.
2
Inhaled Tobramycin for Treatment of Ventilator-Associated Pneumonia: The Interplay of Patient, Drug, and Device.
Respir Care. 2022 Jan;67(1):151-153. doi: 10.4187/respcare.09852.
3
Aerosolized tobramycin for Pseudomonas aeruginosa ventilator-associated pneumonia in patients with acute respiratory distress syndrome.
Pulm Pharmacol Ther. 2017 Aug;45:142-147. doi: 10.1016/j.pupt.2017.04.008. Epub 2017 Apr 24.
4
Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
Respir Care. 2012 Aug;57(8):1226-33. doi: 10.4187/respcare.01556. Epub 2012 Feb 17.
5
Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study.
Surg Infect (Larchmt). 2007 Feb;8(1):73-82. doi: 10.1089/sur.2006.051.
6
Aerosolized antibiotic therapy: a forward aerial assault or forced contingency for ventilator-associated pneumonia?
Respir Care. 2012 Aug;57(8):1348-9. doi: 10.4187/respcare.02016.
7
Intermittent administration of inhaled tobramycin in patients with cystic fibrosis.
J Pediatr. 1999 Jul;135(1):130.
8
A prospective phase IIA multicenter double-blinded randomized placebo-controlled clinical trial evaluating the efficacy and safety of inhaled Tobramycin in patients with ventilator-associated pneumonia (iToVAP).
Anaesth Crit Care Pain Med. 2023 Oct;42(5):101249. doi: 10.1016/j.accpm.2023.101249. Epub 2023 May 20.
9
A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.
Paediatr Drugs. 2007;9 Suppl 1:21-31. doi: 10.2165/00148581-200709001-00004.
10
Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
Chest. 2006 Nov;130(5):1503-10. doi: 10.1378/chest.130.5.1503.
引用本文的文献
1
Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: A narrative review.
J Intensive Med. 2024 Feb 29;4(3):287-298. doi: 10.1016/j.jointm.2023.12.007. eCollection 2024 Jul.
2
Efficacy of adjunctive inhaled colistin and tobramycin for ventilator-associated pneumonia: systematic review and meta-analysis.
BMC Pulm Med. 2024 May 2;24(1):213. doi: 10.1186/s12890-024-03032-7.
3
Optimization of an in vitro Pseudomonas aeruginosa Biofilm Model to Examine Antibiotic Pharmacodynamics at the Air-Liquid Interface.
NPJ Biofilms Microbiomes. 2024 Mar 1;10(1):16. doi: 10.1038/s41522-024-00483-y.
4
Practical Lessons on Antimicrobial Therapy for Critically Ill Patients.
Antibiotics (Basel). 2024 Feb 6;13(2):162. doi: 10.3390/antibiotics13020162.
5
Aminoglycosides for the Treatment of Severe Infection Due to Resistant Gram-Negative Pathogens.
Antibiotics (Basel). 2023 May 6;12(5):860. doi: 10.3390/antibiotics12050860.
6
Aerosolised antibiotics in critical care.
Intensive Care Med. 2023 Jul;49(7):848-852. doi: 10.1007/s00134-023-07036-5. Epub 2023 Apr 21.
7
How to Use Nebulized Antibiotics in Severe Respiratory Infections.
Antibiotics (Basel). 2023 Jan 28;12(2):267. doi: 10.3390/antibiotics12020267.
8
Aerosolized polymyxins for ventilator-associated pneumonia caused by extensive drug resistant Gram-negative bacteria: class, dose and manner should remain the trifecta.
Ann Intensive Care. 2022 Oct 17;12(1):97. doi: 10.1186/s13613-022-01068-8.
9
Optimizing Antimicrobial Drug Dosing in Critically Ill Patients.
Microorganisms. 2021 Jun 28;9(7):1401. doi: 10.3390/microorganisms9071401.
本文引用的文献
1
Why don't we have more inhaled antibiotics to treat ventilator-associated pneumonia?
Clin Microbiol Infect. 2019 Oct;25(10):1195-1199. doi: 10.1016/j.cmi.2019.04.018. Epub 2019 Apr 26.
2
Aerosolized antibiotics for ventilator-associated pneumonia: a pairwise and Bayesian network meta-analysis.
Crit Care. 2018 Nov 15;22(1):301. doi: 10.1186/s13054-018-2106-x.
3
A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia: IASIS Trial.
Chest. 2017 Jun;151(6):1239-1246. doi: 10.1016/j.chest.2016.11.026. Epub 2016 Nov 24.
4
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.
Clin Infect Dis. 2016 Sep 1;63(5):e61-e111. doi: 10.1093/cid/ciw353. Epub 2016 Jul 14.
Zotero 插件